CBD Rights Fight: A patient coalition in the Czech Republic is pushing back on proposed CBD restrictions, urging the government and EU to publish the underlying proof instead of treating CBD like a “drug precursor.” Public Health & Mental Health: A new report says 1 in 5 depressed Americans are self-medicating with mixes that can include cannabis, CBD, and weight-loss drugs—highlighting how people are bypassing standard care. Medical Cannabis Access: Alabama’s medical cannabis program is gaining momentum, with more than 100 patients buying in its first week. Policy Watch: South Carolina GOP candidates say they’re open to signing medical marijuana legalization, but want guardrails to prevent recreational expansion. Community Safety: Denver is reminding trail users that e-bikes are allowed while e-motorcycles and mopeds are not, and it reiterates a no-marijuana/illegal drugs rule on trails. Industry & Research: Leafwell published a new PTSD study supporting medical cannabis for chronic pain and complex conditions. Cultivation Ops: DRM announced a “Core 7” collaboration aimed at helping commercial cannabis operators streamline design and operations.
AGP Executive Report
Your go-to archive of top headlines, summarized for quick and easy reading.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Medical Cannabis Access: Alabama’s program is moving fast: over 100 qualifying patients bought medical cannabis in the first week after the first dispensary opened in Montgomery, with 481 applications and 446 approvals reported. Driving & Legal Clarity: An ACT Greens bill would treat medicinal cannabis like other prescribed meds by focusing on impairment, not just THC presence on roadside tests, aiming to end a “double standard.” Older Adults & Symptom Relief: New research in JAMA Network Open finds adults 60+ are increasingly using edible cannabis for pain, sleep, and mental health—often to avoid pharmaceuticals or after other options fail. Public Safety & Enforcement: Nigeria’s customs and NDLEA intercepted 1.81 tonnes of “Canadian Loud” cannabis at Lagos’ Apapa Port, plus expired pharmaceuticals, worth about ₦12.7bn duty-paid. Policy Push for Psychedelics: North Carolina lawmakers are seeking $5.4m to study psychedelic medicines for military veterans and trauma-impacted groups, framing it as bipartisan mental health innovation. Community-Level Cannabis: Forest Lake, Minnesota opened its first cannabis dispensary, with the mayor among owners, while a separate local case sparked debate over cannabis and driving after a Facebook post.
CBD/IBS Research: GreenSpace Labs reported preliminary Phase 2 pilot results for its oral cannabidiol-based IBS therapy (GSL-01-001), with 12-week symptom improvements across pain, bloating, nausea and more, plus stable stool consistency. Hemp Policy Watch: Congressional researchers say the FDA missed a deadline to publish required cannabinoid lists and clarify the definition of “containers,” as federal hemp rules are set to shift again later this year. Kratom Crackdown: Salem, Kansas moved toward banning kratom sales at convenience and tobacco stores after reports of overdoses and incapacitations; Missouri also saw settlements that halt sales of concentrated 7-OH products. Cannabis Safety/Health: Spain clinicians are raising awareness of cannabinoid hyperemesis syndrome (CHS), describing severe cyclical vomiting in daily cannabis users and noting heat/capsaicin as symptom relief. State Medical Cannabis Update: Kentucky is ending an out-of-state medical marijuana conditional pardon, requiring patients to apply for a Kentucky card instead. Industry/Advocacy: Vlasic Labs’ Michigan Vlasic Classic will raise funds for the Forgotten Prisoner Foundation, supporting Jarred Shaw’s family while he remains incarcerated in Indonesia on cannabis-related charges.
Kentucky Medical Cannabis Access: Gov. Andy Beshear says Kentuckians can no longer bring medical marijuana from other states; the 2022 conditional pardon ends July 1, with patients shifting to the state card system as more than 24,000 people are already approved. Massachusetts Cannabis Ballot Fight: The state’s high court cleared a measure that would roll back adult-use cannabis sales, rejecting claims the AG’s summary left out key details. Hemp THC Drinks Push: A GOP draft bill would keep hemp THC beverages federally legal (up to 5mg delta-9 THC/serving) with federal permitting and a proposed tax. CBD for Sleep Research: A new review/meta-analysis finds the strongest sleep benefits tied to CBD and CBN (and combos), not primarily THC, with THC-linked products showing more adverse effects. Adolescent Brain Study: A large ABCD study reports cannabis use is linked to slower cognitive development during key teen years, with THC implicated. EU Drug Crisis Plan: EU leaders back a coordinated approach targeting organised trafficking and adding overdose prevention tools, as overdose deaths remain extremely high. Public Health/Policy Watch: Illinois bans “intoxicating hemp” sales to minors and tightens oversight; India temporarily restricts Telegram ahead of NEET-UG to curb exam fraud.
Cannabis & Sleep Research: A new systematic review/meta-analysis in the Journal of the American Association of Nurse Practitioners says the strongest sleep improvements were linked to CBD and CBN (and combos), not primarily THC—while THC-heavy products showed more adverse effects. Adolescent Brain Warning: The large ABCD Study (11,036 kids) reports cannabis use is tied to slower cognitive development during key teen years, with THC implicated. Hemp THC Drinks Push: A GOP lawmaker is circulating draft federal legislation to keep hemp THC beverages legal, setting a 5mg delta-9 THC-per-serving limit and federal oversight/tax. Medical Cannabis Access (Kentucky): Kentucky Gov. Andy Beshear says patients can’t bring out-of-state medical marijuana into the state starting July 1, citing enough local dispensaries and product; new qualifying conditions were also added. Cannabinoid Science Tools: NIST added dozens of new cannabis compounds to its mass-spectra library, expanding resources for forensics and biomedical research. Public Health & Policy: Senator Roger Marshall renewed calls to crack down on 7-OH, warning it’s being sold in ways that target teens. Care Model (Netherlands): A Nijmegen care home reports regulated daily alcohol and cannabis use for older residents with addiction, aiming to help people who fall between services.
Cannabis Policy: Illinois moves to protect kids by banning “intoxicating hemp” sales to anyone under 21, with tighter rules coming later for packaging and marketing. Medical Access: Alabama’s first medical cannabis dispensary reports 102 patients buying products in its first week, with demand rising fast. Clinical Research: A new federal analysis estimates more than 8 million Americans used psilocybin in the past year, adding fuel to the broader mental-health conversation around psychedelics. Public Health & Safety: A neurologist warns that using cannabis for sleep isn’t harmless and can trap people in dependency cycles. Enforcement & Supply: UK police say a driver was stopped for speeding and cannabis worth £142,500 was found in the boot; in the Bahamas, the RBDF recovered 12 bales of suspected hydroponic marijuana worth about $718,000. Industry Watch: Alcohol sales are slipping in the U.S., with cannabis and health trends often cited as part of the shift.
Hemp Law Overhaul (Illinois): Gov. JB Pritzker signed SB 3222 to ban “intoxicating hemp” sales to anyone under 21, with tighter rules coming in November 2026 (child-proof packaging, anti-misleading marketing, and bringing products under the state’s cannabis framework). Medical Cannabis Uptick (Alabama): Alabama’s first dispensary, Callie’s Apothecary, opened June 4 and already logged 102 qualifying patients buying in 111 transactions—about $14,600 in pre-tax sales—showing demand is real. UK Clinic Growth (Humber): Releaf says it now has 600+ patients across the region on regulated medical cannabis, including 532 in Hull, with conditions ranging from chronic pain to anxiety, depression, and sleep issues. Cannabis Use in the Wild (Psychedelics): A new federal analysis estimates more than 8 million Americans used psilocybin in the past year (nearly 3% of the population), with users skewing younger and higher-income. Public Safety & Enforcement: Separate reports highlight cannabis in criminal cases and drug busts, including a Manchester Airport “drugs mule” case and a Philippines operation recovering over PHP 2.8M in suspected dried marijuana. Research Watch (Appetite): University of Calgary researchers report rats exposed to cannabis vapor show “munchies,” supporting the idea that cannabis can drive hunger-related brain circuits.
Medical Cannabis Policy: Kentucky’s governor and GOP leaders are trading barbs over medical marijuana prosecutions and an expansion order, with lawmakers pushing for stricter enforcement against licensees while advocates argue patients shouldn’t lose access. CBD/Health Research: A topical CBD gel study on post-workout soreness found no meaningful improvement in perceived pain or muscle damage markers, adding to mixed results on CBD for recovery. Sleep & Nutrition: New reporting highlights magnesium-rich foods (including hemp seeds and pumpkin seeds) as potential helpers for sleep and stress regulation. Drug Enforcement: Police in Benguet recovered about PHP 2.8M in suspected dried marijuana from an abandoned vehicle, while a separate case in Cyprus saw a rider arrested with cannabis and cocaine. Legal/Regulatory Watch: Tennessee’s new THCA ban is set to start July 1, threatening smokable hemp products and raising fears of closures and job losses. Safety/Use Caution: A piece on cannabis withdrawal describes intense symptoms after stopping high-THC vaping, underscoring that quitting can be rough.
Medical Cannabis Policy Clash (Kentucky): Kentucky lawmakers are pushing back hard on Gov. Andy Beshear’s medical marijuana expansion, with GOP leaders calling for prosecutions of agencies and providers who follow the updated qualifying conditions. CBD/THC Safety & Research: A topical CBD soreness study found no meaningful benefit versus placebo, adding to mixed results on CBD for recovery. Cannabis & Driving/Use Concerns: Australia is moving toward a THC driving limit for medicinal cannabis users, while other coverage highlights ongoing debate over cannabis psychosis risk and public trust in cannabis medicine. Public Health & Sleep: Separate reporting warns that using cannabis for sleep may create a dependency cycle, and another piece ties magnesium-rich foods to better sleep and stress regulation. Enforcement & Seizures: Police in Cyprus arrested a motorcyclist with 18 packets of cannabis plus cocaine, and a UK court ruling emphasized the need for chemist reports before certain cannabis trafficking cases can be moved up. Community Health (Gardening): A community garden project is framed as a healing tool, with research linking plants and gardening to lower stress and better wellbeing.
Kentucky Medical Cannabis: Gov. Andy Beshear is ending the out-of-state purchase option for patients starting July 1, after expanding qualifying conditions via executive order—while GOP leaders push to prosecute agencies and licensees for “unlawful expansion,” escalating the political fight over access. Medical Cannabis & Courts: A British woman’s bid to fast-track a cannabis drug-trial transfer was rejected by Malaysia’s Court of Appeal, with judges saying a chemist’s report confirming drug type and weight is required before the case can move up. CBD/Health Research: A new report highlights rising therapeutic cannabis use among older adults in New Hampshire, with participation up across age groups. Cannabis & Mental Health: A fresh discussion revisits concerns that THC exposure can trigger or worsen psychosis risk, especially for people with vulnerability during adolescence/young adulthood. Industry Watch: Avicanna closed a non-brokered private placement to fund working capital, production, and cannabinoid research. Public Health/Policy: New Hampshire’s therapeutic program growth and Kentucky’s access changes keep the spotlight on how rules shape real-world cannabis use.
Medical Cannabis Access: Ukraine’s medical cannabis program is now operational, with THC capsules dispensed to veterans with chronic neuropathic/phantom limb pain and a woman with MS across multiple pharmacies. State Market Updates: Alabama’s medical cannabis rollout is moving fast—its first dispensary reported 102 patients buying products in 111 transactions, and the commission reopened applications for testing lab licenses. Hemp vs THC Legal Fight: Ohio’s restrictions on hemp-derived THC products are headed to court, with Michigan businesses watching closely as the outcome could reshape the broader hemp cannabinoid market. Product Safety Warning: France’s drug market is seeing more adulterated cannabis and other drugs, with users sometimes ingesting substances they didn’t expect. Youth Use Trends: A new review finds NEET youth (15–29) face nearly double the risk for tobacco use and more than double the risk for cannabis use versus peers. CBD/Wellness Angle: A roundup highlights magnesium-rich foods linked to better sleep and stress regulation, including hemp seeds and pumpkin seeds.
CBD for pets: Trait Biosciences says its water-soluble CBD82S™ topical ingredient showed owner-reported improvements in mobility and comfort over a 14-day in-home evaluation for companion animals with joint discomfort. Medical cannabis policy fight: Kentucky lawmakers and Gov. Andy Beshear are trading barbs over an executive-order expansion of qualifying medical cannabis conditions, with Republicans pushing for enforcement against licensees they say are following an “unlawful” directive. Medical cannabis access expands in Georgia: Georgia’s Senate Bill 220 rolls out more medical cannabis options starting July 1, including flower and vape products aimed at faster relief for chronic pain patients. Older adults & edibles: A new survey-based study finds adults 60+ are trying edible cannabis mainly for pain and sleep, often as an alternative after other options ran out—while still worrying about THC impairment and fall risk. Cannabis in the real world: South Carolina lawmakers weigh how to regulate THC seltzers and kratom amid public health concerns and legal uncertainty. Food & health crossover: New research suggests GLP-1 drugs may expand beyond weight loss into broader therapies, with knock-on effects for food and beverage demand.
CBD for pets: Trait Biosciences says its water-soluble CBD82S™ topical ingredient showed owner-reported mobility and comfort changes in a 14-day in-home evaluation of companion animals with joint discomfort. Medical cannabis travel confusion: Michigan travelers are getting mixed signals after TSA updated guidance on flying with medical marijuana, while Delta says it still follows federal rules. Older adults turning to edibles: A new survey study finds many adults 60+ use edible cannabis mainly for pain and sleep—not to get high—while weighing risks like impairment and falls. THC drinks policy pressure (SC): South Carolina lawmakers are debating how to regulate THC seltzers and kratom as bars market them to younger consumers. Industry move: Edibles.com promoted Thomas Winstanley to President as it pushes further into hemp-derived THC and functional wellness. Plant-health angle: Lawn experts stress mowing height and deep, less-frequent watering to help turf crowd out weeds.
CBD & Cancer Fundraising: Deni Angels of Chaos hit a $30,000 goal for the Cancer Council after a CBD pop-up and community sausage sizzles, with more rally fundraising planned across remote parts of Australia. FDA & Pain Treatment: The FDA granted Breakthrough Therapy Designation to VER-01, a cannabis-derived full-spectrum drug for chronic low back pain, citing Phase 3 results showing meaningful pain reduction and better GI tolerability than opioids. Policy Clash (Kentucky): Kentucky lawmakers are pushing the state AG to prosecute cannabis licensees tied to Gov. Beshear’s expansion of qualifying medical conditions, including serious diseases like ALS, HIV/AIDS, and fibromyalgia. Hemp Retail Rules (Pennsylvania): Pennsylvania’s Senate Bill 49 failed to advance, leaving regulation of intoxicating hemp THC products largely unchanged despite calls for tighter limits and a Cannabis Control Board. Youth Use & Risks: New reporting highlights rising cannabis use among teens and the potential for dependence and mental health impacts, urging balanced conversations about benefits and harms. Medical Cannabis Access (Rescheduling): Coverage continues around federal medical marijuana rescheduling and what it could mean for research and patient access. Health & Safety (Boating): A drowning report in Saskatchewan notes alcohol and marijuana can be factors, with life jackets stressed as a key prevention step.
Cannabis Policy: A new federal move to reschedule medical marijuana to Schedule III is framed as a big deal for Michigan operators, mainly because it could ease the tax hit that kept companies from deducting normal business costs. Veterans Access: A VA FOIA-based report says veterans still can’t get cannabis through official channels, but internal rules now spell out how clinicians should talk about it. Cancer + Sleep/Anxiety: A new randomized study finds cannabis oil extracts can meaningfully help about half of cancer patients with sleep-related symptoms and anxiety, with different people responding best to different THC/CBD mixes. Hemp Gummies Age Limits: North Carolina lawmakers push to ban hemp-derived gummies and other consumables for anyone under 21, with similar rules proposed for kratom products. Local Enforcement: Southern Iowa growers are prioritizing weed and disease scouting after wet weather raises tar spot risk. Public Safety + CBD: A Venice canal death inquest says a British tourist went out to smoke CBD and later fell into the water. Research/Health: GLP-1 drugs may affect depression through a gut-brain pathway, according to new animal and lab findings. Funding: Incannex Healthcare reports an A$6.0M R&D tax incentive refund, with more expected. Workplace Rules: A congressional panel blocks federal workers’ comp coverage for marijuana-derived treatment, even after rescheduling.
Medical Cannabis Access & Policy: Kentucky’s medical cannabis clinic operator says the state’s expansion is driving a steady flow of new patients, with doctors certifying eligibility for the card needed to buy in-state products. CBD/THC Product & Safety: The DEA is warning World Cup travelers that fentanyl can be hidden in pills and can be mixed with drugs like marijuana and cocaine, urging people not to experiment. Youth Health & Vaping: Pittsburgh City Council approved new restrictions on vape shops, creating a zoning category that includes cannabinoid products like CBD and Delta-8 THC (medical dispensaries are exempt). Mental Health & Sleep: A Colorado youth health survey highlights “protective factors” like having an adult to turn to, while new research links more daily steps with better sleep and mental health in college students. Cannabis in the News (Enforcement): Police in the Philippines arrested teens in a buy-bust operation after suspected marijuana sales and additional packs were found. Broader Drug Trends: A new EU drug report flags more potent substances, shifting routes, and continued opioid-related overdose deaths across Europe.
Medical Cannabis Access & Delivery: Texas patients in the Compassionate Use Program can now use vaporization products, with same-day access via physician appointments and digital prescriptions. Policy & Road Safety: Australia is moving toward a “medically prescribed THC” driving limit (50 ng/mL in saliva) to avoid penalizing patients who aren’t impaired, while Kentucky lawmakers are pushing to prosecute agencies that back Beshear’s medical cannabis expansion. Research & Regulation: Federal officials are reconsidering marijuana’s Schedule I status, which could reshape research and patient access; meanwhile, a report says rescheduling is prompting changes for research and access. Pain & Product News: Germany approved Exilby, a marijuana-derived oral tincture for chronic pain, aiming to reduce reliance on opioids. State-by-State Market Moves: Florida’s MMJ Health is offering $99 medical marijuana evaluations for new patients through June 2026. Public Health Watch: Europe detected 50 new psychoactive substances in 2025, and cannabis/THC use among youth is rising alongside nicotine co-use. Nutrition for Sleep: New reporting highlights magnesium-rich foods as linked to improved sleep and stress regulation. Safety Alerts: Wyoming health officials warn about rabies and West Nile virus as summer risks increase. CBD/Wellness Adjacent: A magnesium-food roundup and a CBD patch promo for menopausal aches both point to growing consumer interest in sleep and pain support.
Regulatory Pressure on Hemp/CBD: Texas AG Ken Paxton launched a glyphosate residue probe, sending Civil Investigative Demands to Bayer and PepsiCo over alleged consumer-protection violations—another reminder that “wellness” supply chains are under scrutiny. Sleep & CBD/Cannabis Use: A new American Academy of Sleep Medicine survey found 33% of adults say cannabis helps them sleep, while 11% report no benefit and 8% report worse sleep; the group warns about daytime sleepiness, impaired driving, dependence, and withdrawal. Criminal Justice & Cannabis: In the UK, a prisoner at HMP Bristol allegedly told to “just smoke some weed” for depression raises alarms about mental-health care behind bars. Medical Cannabis Expansion: Alabama’s first medical dispensary opened in Montgomery, with more storefronts planned; medical cannabis remains illegal recreationally. Vaping Health Warning: A University of Alberta study links early-life e-cigarette exposure to reduced blood flow and exercise tolerance, suggesting faster harm than expected. Kratom Under Fire: Brandon Clarke’s death is tied to scrutiny of kratom products after police found “100% pure mitragyna speciosa.” Cannabis Enforcement: India customs seized hydroponic weed worth ₹5.38 crore at Delhi’s IGI airport, hidden inside geysers.
Hemp vs. CBD market shakeup: Congress is moving toward restrictions that could wipe out or sharply limit hemp-derived cannabinoid products—THCA flower, Delta-8 gummies, and THC drinks—across Michigan and Ohio, with sleep, pain, and “alcohol alternative” shoppers feeling the hit first. Medical cannabis access: Alabama’s medical program took a big step forward as the state’s first dispensary opened in Montgomery, letting qualifying patients legally buy products for conditions like MS and PTSD. Older adults turning to weed: New research highlights a surge in cannabis use among adults over 60, driven by aches, sleep trouble, and mental-health needs. Public health & youth vaping: Illinois’ OSF Alton is pushing parents to watch for vaping signs and warns vapes can include cannabis and aren’t FDA-regulated. Policy fight in Idaho: Idaho lawmakers approved ballot language for a constitutional amendment that would block voters from legalizing marijuana via initiative. Safety spotlight: A doctor’s Q&A on COPD flags that tobacco and marijuana smoking can fit COPD risk, but diagnosis needs proper lung testing. Drug enforcement: Customs in India seized hydroponic weed hidden in geysers at Delhi airport, while multiple local arrest reports also cite marijuana and meth charges.
Medical Travel Update: TSA updated its medical marijuana guidance, clarifying what patients can bring in carry-on and checked bags and urging people to wait until they arrive before using cannabis. Public Health & Safety: UK officials warn about “dangerous” contaminated drugs, including nitazenes reportedly found in seized batches, as overdoses and sudden deaths raise alarm. CBD/Neuro Research: New studies keep pointing to cannabinoids’ potential in brain inflammation and Alzheimer’s models, adding to the growing research thread around CBD-like compounds and neuro health. Clinical Q&A (COPD): A reader asked Dr. Roach about a daily productive cough and marijuana use; he stressed COPD diagnosis needs symptoms plus lab breathing tests, and that spirometer numbers alone don’t confirm lung function. Policy Watch (Psychedelics): Missouri lawmakers pushed to allow psychedelic-assisted therapy clinical trials for veterans, with MDMA-assisted therapy trials highlighted as PTSD-focused momentum. Legal/Access: Kentucky expanded medical cannabis access via executive order, adding qualifying conditions and widening eligibility. Caregiver/Community: A UK recovery charity is raising £1M by having its founder sleep rough across 26 cities to expand addiction treatment capacity.
Sign up for:
Medical Bud News
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.